AEterna Zentaris Inc (AEZS)
1.96
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 11:35
AEterna Zentaris Cash from Operations (TTM): -17.12M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.12M |
September 30, 2023 | -15.16M |
June 30, 2023 | -15.72M |
March 31, 2023 | -16.28M |
December 31, 2022 | -13.68M |
September 30, 2022 | -12.67M |
June 30, 2022 | -10.21M |
March 31, 2022 | -8.997M |
December 31, 2021 | -8.581M |
September 30, 2021 | -3.65M |
June 30, 2021 | -3.955M |
March 31, 2021 | -2.73M |
December 31, 2020 | -4.129M |
September 30, 2020 | -9.601M |
June 30, 2020 | -10.40M |
March 31, 2020 | -10.16M |
December 31, 2019 | -10.72M |
September 30, 2019 | -10.45M |
June 30, 2019 | -10.29M |
March 31, 2019 | -12.90M |
December 31, 2018 | 6.825M |
September 30, 2018 | 4.977M |
June 30, 2018 | 1.879M |
March 31, 2018 | 0.764M |
December 31, 2017 | -22.91M |
Date | Value |
---|---|
September 30, 2017 | -26.52M |
June 30, 2017 | -26.68M |
March 31, 2017 | -27.12M |
December 31, 2016 | -29.01M |
September 30, 2016 | -29.27M |
June 30, 2016 | -30.72M |
March 31, 2016 | -32.51M |
December 31, 2015 | -33.84M |
September 30, 2015 | -34.03M |
June 30, 2015 | -33.43M |
March 31, 2015 | -31.69M |
December 31, 2014 | -31.08M |
September 30, 2014 | -19.06M |
June 30, 2014 | -20.89M |
March 31, 2014 | -23.68M |
December 31, 2013 | -19.98M |
September 30, 2013 | -32.18M |
June 30, 2013 | -30.94M |
March 31, 2013 | -28.30M |
December 31, 2012 | -30.82M |
September 30, 2012 | -30.72M |
June 30, 2012 | -33.97M |
March 31, 2012 | -35.45M |
December 31, 2011 | -26.24M |
September 30, 2011 | -25.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.12M
Minimum
Dec 2023
-2.73M
Maximum
Mar 2021
-10.24M
Average
-10.29M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |